Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate

Infection and Immunity

Volumn 73, Issue 11, 2005, Pages 7381-7389

  Niedziela, Tomasz ^a,c   Letowska, Iwona ^b   Lukasiewicz, Jolanta ^a   Kaszowska, Marta ^a   Czarnecka, Anna ^a   Kenne, Lennart ^c   Lugowski, Czeslaw ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DODECASACCHARIDE; ENDOTOXIN ANTIBODY; EPITOPE; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; LIPOOLIGOSACCHARIDE; METHYL GROUP; MONOMER; NITRIC OXIDE; PENTASACCHARIDE; PERTUSSIS VACCINE; POLYSACCHARIDE; TETANUS TOXOID; TRISACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; CONJUGATE; CONTROLLED STUDY; COVALENT BOND; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIGH RESOLUTION MAGIC ANGLE SPINNING NUCLEAR MAGNETIC RESONANCE; IMMUNOBLOTTING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PURIFICATION; RABBIT; SATURATION TRANSFER DIFFERENCE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPECTROSCOPY; STRUCTURE ANALYSIS;

ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CARBOHYDRATE CONFORMATION; CELL LINE; ENDOTOXINS; EPITOPE MAPPING; GENE EXPRESSION REGULATION; IMMUNE SERA; IMMUNOCONJUGATES; IMMUNODOMINANT EPITOPES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; NITRIC OXIDE; PERTUSSIS VACCINE; RABBITS; TETANUS TOXOID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27744606564     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.11.7381-7389.2005     Document Type: Article

References (53)

1. Ayme, G., M. Caroff, R. Chaby, N. Haeffher-Cavaillon, A. Le Dur, M. Moreau, M. Muset, M. C. Mynard, M. Roumiantzeff, D. Schulz, and L. Szabo. 1980. Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties. Infect. Immun. 27:739-745.
2. Barnes, M. G., and A. A. Weiss. 2001. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect. Immun. 69:3067-3072.
3. Caroff, M., J. Brisson, A. Martin, and D. Karibian. 2000. Structure of the Bordetella pertussis 1414 endotoxin. FEBS Lett. 477:8-14.
4. Caroff, M., R. Chaby, D. Karibian, J. Perry, C. Deprun, and L. Szabo. 1990. Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J. Bacteriol. 172: 1121-1128.
5. Chaby, R., and M. Caroff. 1988. Lipopolysaccharides of Bordetella pertussis endotoxin, p. 247-271. In Pathogenesis and immunity in pertussis. John-Wiley & Sons, Chichester, United Kingdom.
6. de Melker, H. E., J. F. Schellekens, S. E. Neppelenbroek, F. R. Mooi, H. C. Rumke, and M. A. Conyn-van Spaendonck. 2000. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg. Infect. Dis. 6:348-357.
7. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105.
8. Flak, T. A., and W. E. Goldman. 1999. Signalling and cellular specificity of airway nitric oxide production in pertussis. Cell. Microbiol. 1:51-60.
9. Flak, T. A., L. N. Heiss, J. T. Engle, and W. E. Goldman. 2000. Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect. Immun. 68:1235-1242.
10. Goddard, T. D., and D. G. Kneller. 2001. SPARKY, 3rd ed. University of California, San Francisco.
11. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
12. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
13. Gzyl, A., E. Augustynowicz, D. Rabczenko, G. Gniadek, and J. Slusarczyk. 2004. Pertussis in Poland. Int. J. Epidemiol. 33:358-365.
14. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203-210.
15. Heininger, U. 2001. Recent progress in clinical and basic pertussis research. Eur. J. Pediatr. 160:203-213.
16. Jachymek, W., T. Niedziela, C. Petersson, C. Lugowski, J. Czaja, and L. Kenne. 1999. Structures of the O-specific polysaccharides from Yokenella regensburgei (Koserella trabulsii) strains PCM 2476, 2477, 2478, and 2494: high-resolution magic-angle spinning NMR investigation of the O-specific polysaccharides in native lipopolysaccharides and directly on the surface of living bacteria. Biochemistry 38:11788-11795.
17. Jennings, H. J., and C. Lugowski. 1981. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127:1011-1018.
18. Jennings, H. J., C. Lugowski, and F. E. Ashton. 1984. Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis. Infect. Immun. 43:407-412.
19. Kabat, E. A., and M. M. Mayer. 1967. Precipitin reaction, p. 22-96. In E. A. Kabat and M. M. Mayer (ed.), Experimental immunochemistry. Charles C Thomas, Springfield, Ill.
20. Kossaczka, Z., J. Shiloach, V. Johnson, D. N. Taylor, R. A. Finkelstein, J. B. Robbins. and S. C. Szu. 2000. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect. Immun. 68:5037-5043.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Le Blay, K., M. Caroff, F. Blanchard, M. B. Perry, and R. Chaby. 1996. Epitopes of Bordetella pertussis lipopolysaccharides as potential markers for typing of isolates with monoclonal antibodies. Microbiology 142:971-978.
23. Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods 126:109-117.
24. Lugowski, C., W. Jachymek, T. Niedziela, A. Romanowska, D. Witkowska, and E. Romanowska. 1995. Lipopolysaccharide core region of Hafnia alvei- serological characterization. FEMS Immunol. Med. Microbiol. 10:119-124.
25. Lugowski, C., W. Jachymek, T. Niedziela, and S. Rowinski. 1996. Serological characterisation of anti-endotoxin sera directed against the conjugates of oligosaccharide core of Escherichia coli type R1, R2, R3, J5 and Salmonella Ra with tetanus toxoid. FEMS Immunol. Med. Microbiol. 16:21-30.
26. Lugowski, C., T. Niedziela, and W. Jachymek. 1996. Anti-endotoxin antibodies directed against Escherichia coli R-1 oligosaccharide core tetanus toxoid conjugate bind to smooth, live bacteria and smooth lipopolysaccharides and attenuate their tumor necrosis factor stimulating activity. FEMS Immunol. Med. Microbiol. 16:31-38.
27. Lugowski, C., and E. Romanowska. 1978. Enterobacterial common antigen: isolation from Shigella sonnei, purification and immunochemical characterization. Eur. J. Biochem. 91:89-97.
28. Lukasiewicz, J., W. Jachymek, T. Niedziela, M. Dzieciatkowska, J. Lakomska, R. Miedzybrodzki, W. Fortuna, S. Szymaniec, M. Misiuk-Hojlo, and C. Lugowski. 2003. Serological characterization of anti-endotoxin serum directed against the conjugate of oligosaccharide core of Escherichia coli type R4 with tetanus toxoid. FEMS Immunol. Med. Microbiol. 37:59-67.
29. Maaheimo, H., P. Kosma, L. Brade, H. Brade, and T. Peters. 2000. Mapping the binding of synthetic disaccharides representing epitopes of chlamydial lipopolysaccharide to antibodies with NMR. Biochemistry 39:12778-12788.
30. Mayer, M., and B. Meyer. 1999. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 38:1784-1788.
31. Meiboom, S., and D. Gill. 1958. Modified spin-echo method for measuring nuclear relaxation times. Rev. Sci. Instrum. 29:688-691.
32. Meyer, B., and T. Peters. 2003. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew. Chem. Int. Ed. Engl. 42:864-890.
33. Mooi, F. R., I. H. van Loo, and A. J. King. 2001. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis. 7:526-528.
34. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
35. Mountzouros, K. T., A. Kimura, and J. L. Cowell. 1992. A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis. Infect. Immun. 60:5316-5318.
36. Petersson, C., T. Niedziela, W. Jachymek, L. Kenne, P. Zarzecki, and C. Lugowski. 1997. Structural studies of the O-specific polysaccharide of Hafnia alvei strain PCM 1206 lipopolysaccharide containing D-allothreonine. Eur. J. Biochem. 244:580-586.
37. Piotto, M., V. Saudek, and V. Sklenar. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2:661-665.
38. Price, C. P., and D. J. Newman. 1993. Precipitation and agglutination methods, p. 134-214. In R. F. Masseyeff, W. H. Albert, and N. A. Staines (ed.), Methods of immunological analysis, vol. 1. VCH Verlagsgesellschaft mbH and VCH Publishers Inc., Weinheim, Germany.
39. Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zahringer, U. Seydel, F. Dipadova, M. Schreier, and H. Brade. 1994. Bacterial endotoxin-molecular relationships of structure to activity and function. FASEB J. 8:217-225.
40. Romanowska, A., E. Katzenellenbogen, M. Kulakowska, A. Gamian, D. Witkowska, M. Mulczyk, and E. Romanowska. 1988. Hafnia alvei lipopolysaccharides: isolation, sugar composition and SDS-PAGE analysis. FEMS Immunol. Med. Microbiol. 1:151-155.
41. Schaeffer, L. M., F. X. McCormack, H. Wu, and A. A. Weiss. 2004. Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J. Immunol. 173:1959-1965.
42. Schmidt, H. H., T. D. Warner, M. Nakane, U. Forstermann, and F. Murad. 1992. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol. 41:615-624.
43. Smith, A. M., C. A. Guzman, and M. J. Walker. 2001. The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol. Rev. 25:309-333.
44. Trollfors, B., T. Lagergard, J. Taranger, E. Bergfors, R. Schneerson, and J. B. Robbins. 2001. Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis. Clin. Diagn. Lab. Immunol. 8:1015-1017.
45. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
46. Turcotte, M. L., D. Martin, B. R. Brodeur, and M. S. Peppler. 1997. Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function. Microbiology 143:2381-2394.
47. Van Loo, I. H., H. G. Van der Heide, N. J. Nagelkerke, J. Verhoef, and F. R. Mooi. 1999. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J. Infect. Dis. 179:915-923.
48. Vliegenthart, J. F. G., H. van Halbeek, and L. Dorland. 1981. The applicability of 500-MHz high-resolution H-1-NMR spectroscopy for the structure determination of carbohydrates derived from glycoproteins. Pure Appl. Chem. 53:45-77.
49. Voller, A., C. Draper, D. E. Bidwell, and A. Bartlett. 1975. Microplate enzyme-linked immunosorbent assay for Chagas' disease. Lancet i:426-428.
50. Watanabe, M., H. Takimoto, Y. Kumazawa, and K. Amano. 1990. Biological properties of lipopolysaccharides from Bordetella species. J. Gen. Microbiol. 136:489-493.
51. Weiss, A. A., P. S. Mobberley, R. C. Fernandez, and C. M. Mink. 1999. Characterization of human bactericidal antibodies to Bordetella pertussis. Infect. Immun. 67:1424-1431.
52. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-89.
53. Zielinski, A., M. Rosinska, M. Czarkowski, and J. Rudowska. 2004. The effectiveness of vaccination with whole-cell pertussis vaccine by age group in Poland 1996-2001. Scand. J. Infect. Dis. 36:114-118.